Zobrazeno 1 - 10
of 193
pro vyhledávání: '"George, Shenouda"'
Autor:
Justine G. Albert, Christopher Lo, Zeev Rosberger, Saul Frenkiel, Michael Hier, Anthony Zeitouni, Karen Kost, Alex Mlynarek, Martin Black, Christina MacDonald, Keith Richardson, Marco Mascarella, Gregoire B. Morand, Gabrielle Chartier, Nader Sadeghi, Khalil Sultanem, George Shenouda, Fabio L. Cury, Melissa Henry
Publikováno v:
Current Oncology, Vol 29, Iss 7, Pp 4438-4454 (2022)
(1) Background: Patients and survivors of head and neck cancer (HNC) are at a high risk of developing body image concerns. Despite the prevalence of body image concerns in patients with HNC, there is a lack of longitudinal research exploring the wide
Externí odkaz:
https://doaj.org/article/2eeb70d0929e45f09a7185ff0810964a
Autor:
Siavosh Vakilian, MD, Jonathan Thébaut, MSc, Russell Ruo, MSc, Sorana Marcovitz, MD, Valérie Panet-Raymond, MD, George Shenouda, MD, PhD, Khalil Sultanem, MD, Luis Souhami, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 4, Pp 100693- (2021)
Purpose: Previous reports have documented a dose-effect relationship for radiation-induced hypopituitarism in patients receiving therapy near or at the base of the skull. We aimed to characterize this long-term endocrinopathy further by examining the
Externí odkaz:
https://doaj.org/article/40429755d50a45edb06416c796e0635e
Autor:
Tony Shicheng Jin, David Shiqiang Jin, George Shenouda, Miguel Burnier, Bryan Arthurs, Christian El-Hadad
Publikováno v:
Canadian Journal of Ophthalmology. 58:e132-e134
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ecb057ab3a2e2a96a3be33072492a3d
https://doi.org/10.1016/j.jcjo.2022.12.005
https://doi.org/10.1016/j.jcjo.2022.12.005
Autor:
Jobanpreet Dhillon, Daniel Q. Li, Miguel Burnier, George Shenouda, Bryan P. Arthurs, Christian El-Hadad
Publikováno v:
Orbit. :1-7
The current case presentation highlights the potential of cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, as first-line treatment for periocular metastatic cutaneous squamous cell carcinoma (SCC) without requiring curative surgery or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca3fe400a90e0a39475b26bdbc78766a
https://doi.org/10.1080/01676830.2022.2118789
https://doi.org/10.1080/01676830.2022.2118789
Autor:
Quynh-Thu Le, Qiang E. Zhang, John A. Ridge, George Shenouda, Stuart J. Wong, Wade L. Thorstad, Sue S. Yom, Christopher U. Jones, James A. Bonner, Andy M. Trotti, Peter B. Schiff, Steven J. Frank, Lucas K. Vitzthum, Kaveh Zakeri, David I. Rosenthal, Phuc Felix Nguyen-Tân, Hanjie Shen, Loren K. Mell
Purpose:Previous studies indicate that the benefit of therapy depends on patients' risk for cancer recurrence relative to noncancer mortality (ω ratio). We sought to test the hypothesis that patients with head and neck cancer (HNC) with a higher ω
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f904e632f4fad6465278ca6933c2f2d
https://doi.org/10.1158/1078-0432.c.6527897.v1
https://doi.org/10.1158/1078-0432.c.6527897.v1
Autor:
Quynh-Thu Le, Qiang E. Zhang, John A. Ridge, George Shenouda, Stuart J. Wong, Wade L. Thorstad, Sue S. Yom, Christopher U. Jones, James A. Bonner, Andy M. Trotti, Peter B. Schiff, Steven J. Frank, Lucas K. Vitzthum, Kaveh Zakeri, David I. Rosenthal, Phuc Felix Nguyen-Tân, Hanjie Shen, Loren K. Mell
Supplementary Data: Tables S1-S2; Figures S1-S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1689d62e59736f109603e8259032ebc3
https://doi.org/10.1158/1078-0432.22471442
https://doi.org/10.1158/1078-0432.22471442
Autor:
Adam S. Garden, Jonathan Harris, Avraham Eisbruch, K.S. Clifford Chao, William H. Morrison, Paul M. Harari, Todd Allen Swanson, Christopher U. Jones, Sue S. Yom, Sharon A. Spencer, Rufus Scrimger, George Shenouda, Monica Shukla, Harold Y. Lau, Michelle Mierzwa, Pedro Torres-Saavedra, Quynh Thu Le
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97aee4002d2dd3a961e57f7ea1d5a27b
https://doi.org/10.1016/j.ijrobp.2023.02.057
https://doi.org/10.1016/j.ijrobp.2023.02.057
Autor:
Julia Khriguian, Marwan Tolba, Farzin Khosrow-Khavar, Sarah Kordlouie, Marie-Christine Guiot, Bassam Abdulkarim, George Shenouda, Denis Sirhan, Luis Souhami, Valerie Panet-Raymond
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50:428-434
Background:The optimal treatment of adult craniopharyngioma (CP) remains controversial. Although benign, these tumors tend to recur locally. The choice between gross total resection (GTR) versus subtotal resection (STR) with adjuvant or delayed radio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69e6493e4209edfd3c81457d3893d4c1
https://doi.org/10.1017/cjn.2022.28
https://doi.org/10.1017/cjn.2022.28
Autor:
Jimmy J. Caudell, Pedro A. Torres-Saavedra, David I. Rosenthal, Rita S. Axelrod, Phuc Felix Nguyen-Tan, Eric J. Sherman, Randal S. Weber, James M. Galvin, Adel K. El-Naggar, Andre A. Konski, Michelle I. Echevarria, Neal E. Dunlap, George Shenouda, Anurag K. Singh, Jonathan J. Beitler, Adam Garsa, James A. Bonner, Adam S. Garden, Ozer Algan, Jonathan Harris, Quynh-Thu Le
Publikováno v:
Int J Radiat Oncol Biol Phys
PURPOSE: The combination of cisplatin and radiation or cetuximab and radiation improves overall survival of patients with locoregionally advanced head and neck carcinoma. NRG Oncology conducted a phase 3 trial to test the hypothesis that adding cetux
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08dcdb90cc6453e1c4fd3c86b36182df
https://doi.org/10.1016/j.ijrobp.2022.12.015
https://doi.org/10.1016/j.ijrobp.2022.12.015
Autor:
Craig Donaldson, Phuc Felix Nguyen-Tân, Yuhchyau Chen, David I. Rosenthal, Elaine Bigelow, Quynh-Thu Le, Suresh G. Nair Md, Houda Bahig, Michael J. Birrer, Steven J. Frank, Carole Fakhry, John A. Ridge, Maura L. Gillison, Bradley T. Clifford, Jimmy J. Caudell, George Shenouda, Jonathan Harris
Publikováno v:
Head & Neck. 44:158-167
BACKGROUND No risk-stratification strategies exist for patients with recurrent oropharyngeal cancer (OPC). METHODS Retrospective analysis using data from prospective NRG Oncology clinical trials RTOG 0129 and 0522. Eligibility criteria included known
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee036a171a672fb9bd7a3024fc83f235
https://doi.org/10.1002/hed.26915
https://doi.org/10.1002/hed.26915